Stockscreener 앱 받기
58.96
1.14%
-0.60
Vericel Corp 주식(VCEL)의 최신 뉴스
Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail
Equities Analysts Set Expectations for Vericel Q3 Earnings - MarketBeat
Vericel (NASDAQ:VCEL) Earns “Overweight” Rating from Stephens - Defense World
FY2024 EPS Estimates for Vericel Reduced by HC Wainwright - Defense World
FY2024 Earnings Estimate for Vericel Issued By HC Wainwright - MarketBeat
Analyst supports Vericel stock outlook citing MACI Arthro synergies and expansion plans - Investing.com
Vericel (NASDAQ:VCEL) Shares Gap DownShould You Sell? - MarketBeat
Vericel (NASDAQ:VCEL) Receives "Overweight" Rating from Stephens - MarketBeat
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
HC Wainwright Reaffirms "Buy" Rating for Vericel (NASDAQ:VCEL) - MarketBeat
Beyond The Numbers: 5 Analysts Discuss Vericel Stock - Benzinga
Canaccord reaffirms Vericel stock buy rating on preliminary Q4 results - Investing.com
Vericel's preliminary Q4 revenue falls short of analyst expectations; shares fall 11% post market - Investing.com
Vericel expects 2024 net revenue in range of $237 to $237.5 million - MSN
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets - Yahoo Finance
Vericel Co. (NASDAQ:VCEL) Receives $61.14 Consensus PT from Analysts - Defense World
JPMorgan Chase & Co. Has $19.08 Million Stake in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 - Yahoo Finance
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $61.14 - MarketBeat
Vericel (NASDAQ:VCEL) Shares Cross Above 200 Day Moving AverageShould You Sell? - MarketBeat
Vericel Corp prices $17 million public offering of common stock - Reuters
5 Best Stem Cell Companies to Invest In (January 2025) - Securities.io
Vericel Co. (NASDAQ:VCEL) Shares Sold by Principal Financial Group Inc. - Defense World
Principal Financial Group Inc. Has $10.64 Million Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
MML Investors Services LLC Raises Stock Position in Vericel Co. (NASDAQ:VCEL) - Defense World
Geode Capital Management LLC Grows Stock Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel Co. (NASDAQ:VCEL) Shares Acquired by Geode Capital Management LLC - Defense World
Vericel (NASDAQ:VCEL) Upgraded at StockNews.com - MarketBeat
Financial Review: Surrozen (NASDAQ:SRZN) & Vericel (NASDAQ:VCEL) - Defense World
Stifel Financial Corp Increases Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Barclays PLC Boosts Stock Holdings in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel (NASDAQ:VCEL) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
Vericel price target raised to $67 from $61 at Truist - Yahoo Finance
Vericel shares target upgraded, Buy rating on robust growth trajectory - Investing.com
Truist Financial Issues Positive Forecast for Vericel (NASDAQ:VCEL) Stock Price - MarketBeat
Vericel's SWOT analysis: MACI arthro approval boosts cartilage repair stock - Investing.com
Vericel (NASDAQ:VCEL) Shares Up 5.3%Here's What Happened - MarketBeat
TD Cowen lifts Vericel shares target, maintains buy rating on growth prospects - Investing.com
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $59.71 - Defense World
State Street Corp Sells 55,227 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
Bioengineered Artificial Skin Market Growth in Future Scope - openPR
Financial Contrast: Vericel (NASDAQ:VCEL) versus HilleVax (NASDAQ:HLVX) - Defense World
Vericel Co. (NASDAQ:VCEL) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Vericel (NASDAQ:VCEL) Rating Lowered to “Sell” at StockNews.com - Defense World
Wellington Management Group LLP Grows Stock Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 12,375 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel's SWOT analysis: arthroscopic MACI approval boosts stock outlook - Investing.com
BNP Paribas Financial Markets Has $1.35 Million Position in Vericel Co. (NASDAQ:VCEL) - Defense World
Castleark Management LLC Sells 64,040 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
Insider Sell: Paul Wotton Sells 2,600 Shares of Vericel Corp (VC - GuruFocus.com
Vericel director Paul Wotton sells $152,672 in stock By Investing.com - Investing.com Canada
Vericel director Paul Wotton sells $152,672 in stock - Investing.com
Polar Asset Management Partners Inc. Invests $4.97 Million in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Fmr LLC Boosts Holdings in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel (FRA:ATQP) Momentum Rank : 8 (As of Dec. 04, 2024) - GuruFocus.com
13,332 Shares in Vericel Co. (NASDAQ:VCEL) Acquired by Intech Investment Management LLC - MarketBeat
Townsquare Capital LLC Acquires 16,385 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
0.81%
7.69%
자본화:
|
볼륨(24시간):